Rehabilitation centre: Reha Rheinfelden
Rheinfelden, Canton of Aargau, 4310, Switzerland
NCT Number: NCT00858910
The purpose of the study is to examine if patients in the embedded motor imagery (MI) training group (EG1) need less time to perform the motor task than patients in the added MI training group (EG2).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2
Rheinfelden, Canton of Aargau, 4310, Switzerland
The purpose of the study is to examine if patients in the embedded MI training into physiotherapy (EG1) need less time to perform the motor task than patients in the added MI training to physiotherapy (EG2).
A third groups serves a control group (CG) to investigate the effect of the intervention versus a group with a control intervention.
Additionally, semi-structured interviews before and after the intervention will give an insight in the patient's experience with motor imagery (MI), their expectations regarding the intervention and their opinions about MI after the intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MI training encloses the internal rehearsal of a known motor skill without any overt motor output.
The control intervention encloses relaxation and breathing exercises, and information about:
Time frame: 2 weeks
Time frame: 2 weeks
Time frame: 2 weeks
Time frame: 2 weeks
Time frame: 2 weeks
Time frame: 2 weeks
Reha Rheinfelden
Other
Comparison of Embedded and Added Motor Imagery Training to Improve a Motor Skill in Patients After Stroke: a Pilot Randomised Controlled Trial Using a Mixed Methods Approach
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT05589402
Bone Diseases, Brain Diseases
Harlingen, Texas, United States
View Trial DetailsNCT06750692
Brain Diseases, Cardiovascular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial Details